Hear from Your Peers: Strategies for Successful Integrated HIV Prevention and Care Plan Monitoring and Evaluation
Resource updated 06/06/2023
Resource updated 06/06/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 03/06/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 04/10/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Intended for those responsible for documenting and tracking implementation of their jurisdiction's Integrated HIV Prevention and Care Plan, this modifiable work plan from the Pennsylvania Department of Health’s Division of HIV is a helpful starting place. Implementation activities included in the work plan support the four Ending the HIV Epidemic strategies–diagnose, treat, prevent, and respond–plus a fifth strategy, support, to ensure a truly accessible and responsive system of care.
Resource updated 02/28/2024
Resource updated 04/03/2024
Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
Resource updated 03/13/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Workbooks for RWHAP planning bodies and other entities to self-assess their effectiveness.
Resource updated 09/19/2023